Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Leases: 2022-2024

Historic Operating Leases for Praxis Precision Medicines (PRAX) over the last 3 years, with Dec 2024 value amounting to $110,000.

  • Praxis Precision Medicines' Operating Leases fell 95.59% to $110,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $110,000, marking a year-over-year decrease of 95.59%. This contributed to the annual value of $110,000 for FY2024, which is 95.59% down from last year.
  • According to the latest figures from Q4 2024, Praxis Precision Medicines' Operating Leases is $110,000, which was down 74.77% from $436,000 recorded in Q3 2024.
  • Praxis Precision Medicines' 5-year Operating Leases high stood at $3.5 million for Q4 2022, and its period low was $110,000 during Q4 2024.
  • Moreover, its 3-year median value for Operating Leases was $2.1 million (2023), whereas its average is $1.9 million.
  • Data for Praxis Precision Medicines' Operating Leases shows a maximum YoY tumbled of 95.59% (in 2024) over the last 5 years.
  • Quarterly analysis of 3 years shows Praxis Precision Medicines' Operating Leases stood at $3.5 million in 2022, then dropped by 28.71% to $2.5 million in 2023, then slumped by 95.59% to $110,000 in 2024.
  • Its Operating Leases stands at $110,000 for Q4 2024, versus $436,000 for Q3 2024 and $755,000 for Q2 2024.